High blood pressure (HBP) is a major modifiable cardiovascular risk factor which prevalence is gradually increasing. Reducing blood pressure (BP) significantly decreases cardiovascular morbi-mortality. Nevertheless, BP control remains insufficient: only 51% of French patients using antihypertensive drugs achieve the BP control targets. HBP is mostly diagnosed and managed in primary care. Nevertheless, office BP measurements are unreliable for BP control and poorer predict target organ damage. Ambulatory BP measurements are recommended for HBP diagnosis and follow-up. 24-hour ambulatory blood pressure monitoring (ABPM) is the most cost-effective strategy. Its superiority has been demonstrated for HBP diagnosis and cardiovascular prognosis. In France, ABPM is poorly available and little studied in primary care. Therefore, the investigators conducted a regional prospective study to analyze the feasibility and benefits of ABPM among primary care hypertensive patients in daily practice.
Study Type
OBSERVATIONAL
Enrollment
1,067
Groupements des Professionnels de Santé du Pays Beaunois
Beaune, France
SUSPENDEDMaison Universitaire de Santé et de Soins Primaires
Chenôve, France
RECRUITINGCabinet de médecine générale
Garchizy, France
SUSPENDEDMaison de santé de Terre Pleine
Guillon, France
SUSPENDEDMaison de Santé Pluridisciplinaire
Montret, France
RECRUITINGGroupement des Professionnels de Santé de l'Auxois Sud
Pouilly-en-Auxois, France
RECRUITINGMaison de santé de l'Esplanade
Tournus, France
RECRUITINGPrevalence of white-coat hypertension
Proportion of patients with normotension in ABPM (daytime systolic/diastolic BP\< 135/85 mmHg AND/OR nighttime BP\< 120/70 mmHg AND/OR 24-hour BP\< 130/80 mmHg) among the patients with primary care office measured BP≥ 140/90 mmHg
Time frame: at the time of ABPM, up to 30 days after the inclusion consultation
Prevalence of nocturnal hypertension
Proportion of patients with nocturnal high blood pressure in ABPM (nighttime systolic/diastolic BP\> 120/70 mmHg) among the patients with primary care office measured BP≥ 140/90 mmHg
Time frame: at the time of ABPM, up to 30 days after the inclusion consultation
Prevalence of diurnal hypertension
Proportion of patients with diurnal high blood pressure in ABPM (daytime systolic/diastolic BP\> 135/85 mmHg) among the patients with primary care office measured BP≥ 140/90 mmHg
Time frame: at the time of ABPM, up to 30 days after the inclusion consultation
Prevalence of 24-hour hypertension
Proportion of patients with 24-hour high blood pressure in ABPM (24-hour systolic/diastolic BP\> 130/80 mmHg) among the patients with primary care office measured BP≥ 140/90 mmHg
Time frame: at the time of ABPM, up to 30 days after the inclusion consultation
Dipping
Proportion of nighttime mean BP fall, compared to daytime mean BP
Time frame: at the time of ABPM, up to 30 days after the inclusion consultation
ABPM acceptability
Number of patients who have undergone/completed the ABPM
Time frame: at the time of ABPM, up to 30 days after the inclusion consultation
ABPM validity
Number of patients who have had an invalid ABPM according to the criteria of the European society of cardiology
Time frame: at the time of ABPM, up to 30 days after the inclusion consultation
ABPM side effects
Number of major side effects
Time frame: at the time of ABPM, up to 30 days after the inclusion consultation
Deprivation among hypertensive patients
Deprivation status of hypertensive primary care patients, according to the French Assessment of deprivation in Health Examination Centers' (EPICES) score (deprivation if EPICES score\> 30)
Time frame: at the time of ABPM, up to 30 days after the inclusion consultation
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.